These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1933339)

  • 1. The effects of serotonergic stimulation on hippocampal and neocortical slow waves and behavior.
    Robertson B; Baker GB; Vanderwolf CH
    Brain Res; 1991 Aug; 555(2):265-75. PubMed ID: 1933339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of raphe stimulation on hippocampal and neocortical activity and behaviour.
    Peck BK; Vanderwolf CH
    Brain Res; 1991 Dec; 568(1-2):244-52. PubMed ID: 1839967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior.
    Vanderwolf CH; Baker GB
    Brain Res; 1986 May; 374(2):342-56. PubMed ID: 2941111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-dependent cerebral activation: effects of methiothepin and other serotonergic antagonists.
    Watson NV; Hargreaves EL; Penava D; Eckel LA; Vanderwolf CH
    Brain Res; 1992 Nov; 597(1):16-23. PubMed ID: 1477730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint cholinergic-serotonergic control of neocortical and hippocampal electrical activity in relation to behavior: effects of scopolamine, ditran, trifluoperazine and amphetamine.
    Vanderwolf CH; Stewart DJ
    Physiol Behav; 1986; 38(1):57-65. PubMed ID: 3786502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neocortical and hippocampal electrical activity following decapitation in the rat.
    Vanderwolf CH; Buzsaki G; Cain DP; Cooley RK; Robertson B
    Brain Res; 1988 Jun; 451(1-2):340-4. PubMed ID: 3251594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of serotonin-dependent cerebral activation: a possible mechanism of action of some psychotomimetic drugs.
    Vanderwolf CH
    Brain Res; 1987 Jun; 414(1):109-18. PubMed ID: 3620913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neocortical activation: modulation by multiple pathways acting on central cholinergic and serotonergic systems.
    Dringenberg HC; Vanderwolf CH
    Exp Brain Res; 1997 Aug; 116(1):160-74. PubMed ID: 9305825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are the dorsal noradrenergic bundle projections from the locus coeruleus important for neocortical or hippocampal activation?
    Robinson TE; Vanderwolf CH; Pappas BA
    Brain Res; 1977 Dec; 138(1):75-98. PubMed ID: 589470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine does not play an essential role in electrocortical activation during waking behavior.
    Servos P; Barke KE; Hough LB; Vanderwolf CH
    Brain Res; 1994 Feb; 636(1):98-102. PubMed ID: 8156416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A frequency analysis of behavior components of the serotonin syndrome produced by p-chloroamphetamine.
    Kutscher CL; Yamamoto BK
    Pharmacol Biochem Behav; 1979 Dec; 11(6):611-6. PubMed ID: 575425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of serotonin in the control of cerebral activity: studies with intracerebral 5,7-dihydroxytryptamine.
    Vanderwolf CH; Leung LW; Baker GB; Stewart DJ
    Brain Res; 1989 Dec; 504(2):181-91. PubMed ID: 2598021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotoninergic manipulation of the behavioral effects of cocaine in rats.
    Pradhan SN; Battacharyya AK; Pradhan S
    Commun Psychopharmacol; 1978; 2(6):481-6. PubMed ID: 311720
    [No Abstract]   [Full Text] [Related]  

  • 15. Some general anesthetics reduce serotonergic neocortical activation and enhance the action of serotonergic antagonists.
    Dringenberg HC; Vanderwolf CH
    Brain Res Bull; 1995; 36(3):285-92. PubMed ID: 7697382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic stimulation of pituitary-adrenocortical function in rats.
    Fuller RW
    Neuroendocrinology; 1981 Feb; 32(2):118-27. PubMed ID: 7010191
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of serotonergic and cholinergic systems in the aggression-stereotypy complex produced by amphetamine in mice.
    Roliński Z
    Pol J Pharmacol Pharm; 1977; 29(6):591-602. PubMed ID: 304574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain structures involved in the behavioral stimulant effect of central serotonin release.
    Vanderwolf CH; McLauchlin M; Dringenberg HC; Baker GB
    Brain Res; 1997 Oct; 772(1-2):121-34. PubMed ID: 9406964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic effects of apomorphine in rats with altered level of brain serotonin.
    Grabowska M; Michaluk J; Antkiewicz L
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):517-26. PubMed ID: 126051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo increase in hypothalamic cyclic AMP following 5-hydroxytryptophan administration in rats.
    Bundman MC; Browning RA
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):214-20. PubMed ID: 6092975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.